SCHEMBL8639467

SCHEMBL8639467

Oc1ccc(/C(=C\c2ccccc2)c2ccccc2)cc1

nearest known ligand 0.96

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 4/20 0.96
ESR2 Q92731 3/20 0.75
CYP19A1 P11511 4/20 0.61
CYP11B2 P19099 2/20 0.59
PTGS2 P35354 3/20 0.50
CES2 O00748 1/20 0.50
CYP2D6 P10635 1/20 0.49
MEN1 O00255 1/20 0.48
ALDH2 P05091 1/20 0.48
CYP3A4 P08684 1/20 0.48
MAPT P10636 1/20 0.48
HSPD1 P10809 1/20 0.48
F3 P13726 1/20 0.48
MAOA P21397 1/20 0.48
MAOB P27338 1/20 0.48
HSPE1 P61604 1/20 0.48
KMT2A Q03164 1/20 0.48
CYP1B1 Q16678 1/20 0.48
TDP1 Q9NUW8 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1948714 1.00 ESR1 (0.96) ESR1ESR2CYP19A1CYP11B2PTGS2
SCHEMBL1948717 1.00 ESR1 (0.96) ESR1ESR2CYP19A1CYP11B2PTGS2
SCHEMBL641985 0.98 ESR1 (1.00) ESR1ESR2CYP19A1CYP11B2PTGS2
SCHEMBL14354218 0.93 ESR1 (0.83) ESR1ESR2CYP19A1CYP11B2PTGS2
Phenol SCHEMBL18863020 0.93 ESR1 (0.83) ESR1ESR2CYP19A1CYP11B2PTGS2
SCHEMBL4612465 0.91 ESR1 (0.78) ESR1ESR2CYP19A1CYP11B2PTGS2
SCHEMBL55433 0.89 ESR1 (0.74) ESR1ESR2CYP19A1CYP11B2PTGS2
SCHEMBL22046628 0.87 ESR1 (0.72) ESR1ESR2CYP19A1CYP11B2PTGS2
Phosphine SCHEMBL28461311 0.86 ESR1 (0.71) ESR1ESR2CYP19A1CYP11B2PTGS2
SCHEMBL30366689 0.86 ESR1 (0.71) ESR1ESR2CYP19A1CYP11B2PTGS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9656947-B2 Process for creating carbon-carbon bonds using carbonyl compounds CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (C.N.R.S) (FR) 2017-05-23 US disclosed
EP-0720597-B1 TRIARYL-ETHYLENE DERIVATIVES FOR USE IN THERAPY MERRELL PHARMA INC (US) 1998-04-29 EP disclosed
US-5693674-A Method of using triaryl-ethylene derivatives in the treatment and prevention of osteoporosis HOECHST MARION ROUSSEL, INC. (US) 1997-12-02 US disclosed
US-5691384-A Method of using triaryl-ethylene derivatives in the treatment and prevention of osteoporosis HOECHST MARION ROUSSEL, INC. (US) 1997-11-25 US disclosed
US-5684004-A ANTINEOPLASTIC AGENTS, ANTIATHEROSCLEROTIC AGENTS, HYPOCHOLESTEROLEMIC AGENTS MERRELL PHARMACEUTICALS, INC. (US) 1997-11-04 US disclosed
EP-0794771-A1 METHOD OF USING TRIARYL-ETHYLENE DERIVATIVES IN THE TREATMENT AND PREVENTION OF OSTEOPOROSIS HOECHST MARION ROUSSEL, INC. (US) 1997-09-17 EP disclosed
EP-0720597-A1 TRIARYL-ETHYLENE DERIVATIVES FOR USE IN THERAPY MERRELL PHARMACEUTICALS INC. (US) 1996-07-10 EP disclosed
US-5525633-A ANTITUMOR AGENTS, ANTICHOLESTEROL AGENTS MERRELL DOW PHARMACEUTICALS INC. (US) 1996-06-11 US disclosed
WO-1996016646-A1 METHOD OF USING TRIARYL-ETHYLENE DERIVATIVES IN THE TREATMENT AND PREVENTION OF OSTEOPOROSIS HOECHST MARION ROUSSEL, INC. (US) 1996-06-06 WO disclosed
WO-1995008528-A1 TRIARYL-ETHYLENE DERIVATIVES FOR USE IN THERAPY MERRELL PHARMACEUTICALS INC. (US) 1995-03-30 WO disclosed